What is included in this Sample?
- * Market Segmentation
- * Key Findings
- * Research Scope
- * Table of Content
- * Report Structure
- * Report Methodology
Download FREE Sample Report
Scleral Lens Market Size, Share, Growth, and Industry Analysis, By Type (Mini-Scleral Lenses, Large-Scleral Lenses), By Application (Hospital, Eye Clinic, Others), Regional Insights and Forecast to 2035
Trending Insights
Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities
Our Research is the Cornerstone of 1000 Firms to Stay in the Lead
1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
SCLERAL LENS MARKET OVERVIEW
The global Scleral Lens Market size estimated at USD 0.31 billion in 2026 and is projected to reach USD 0.58 billion by 2035, growing at a CAGR of 7.24% from 2026 to 2035.
I need the full data tables, segment breakdown, and competitive landscape for detailed regional analysis and revenue estimates.
Download Free SampleThe Scleral Lens Market is expanding steadily due to the increasing prevalence of corneal disorders, dry eye disease, keratoconus, and post-surgical vision complications. Scleral lenses account for nearly 18% of specialty contact lens fittings worldwide, while more than 45 million people globally use contact lenses for vision correction. Keratoconus affects approximately 1 in 375 individuals in many clinical populations, supporting higher adoption of scleral lenses. More than 82% of patients with irregular corneas achieve improved visual acuity using scleral lenses. Advanced oxygen-permeable materials with oxygen permeability exceeding 140 Dk have improved wearing comfort, while customized fitting technology has increased first-fit success rates to approximately 76%, strengthening the Scleral Lens Market.
The United States represents one of the largest markets for scleral lenses due to advanced eye care infrastructure and increasing diagnosis of corneal diseases. More than 45 million Americans wear contact lenses, while approximately 20 million adults experience chronic dry eye symptoms. Keratoconus affects nearly 200,000 individuals in the country, creating strong demand for specialty lenses. More than 10,000 practicing optometrists provide specialty contact lens fitting services, and over 70% of tertiary eye hospitals offer scleral lens fitting programs. Digital corneal topography adoption exceeds 88% among specialty eye clinics, improving fitting precision and supporting greater acceptance of customized scleral lens solutions.
KEY FINDINGS
- Key Market Driver: More than 62% of specialty contact lens prescriptions are associated with irregular corneas, while over 74% of advanced ocular surface disease patients achieve improved vision, supporting 58% higher adoption of scleral lenses in specialty eye care.
- Major Market Restraint: Nearly 39% of potential users discontinue fitting because of higher costs, 31% experience delayed access to specialists, 27% require multiple fitting sessions, and 24% report limited reimbursement coverage for specialty contact lenses.
- Emerging Trends: Approximately 67% of newly introduced scleral lenses feature customized digital designs, 61% incorporate high oxygen permeability materials, 48% utilize advanced corneal mapping, and 43% support impression-based personalized manufacturing technologies.
- Regional Leadership: North America accounts for nearly 41% market share, Europe contributes 29%, Asia-Pacific represents 22%, while Middle East & Africa holds approximately 8% of global scleral lens demand.
- Competitive Landscape: The leading 5 manufacturers collectively account for nearly 63% market share, while the top 2 companies control approximately 35%, leaving 37% distributed among regional specialty manufacturers.
- Market Segmentation: Mini-scleral lenses contribute approximately 58% of product demand, large-scleral lenses account for 42%, hospitals represent 29% of applications, eye clinics contribute 56%, and other settings account for 15%.
- Recent Development: Nearly 71% of product launches focused on higher oxygen permeability, 54% emphasized digital fitting software, 38% targeted severe dry eye treatment, and 29% introduced enhanced customized manufacturing capabilities.
LATEST TRENDS
The Scleral Lens Market is witnessing significant technological progress driven by personalized vision correction and digital diagnostic innovations. More than 68% of newly fitted scleral lenses are manufactured using advanced computer-guided lathing technology, improving fitting precision by approximately 25% compared with conventional manufacturing methods. Digital corneal topography systems are now installed in over 90% of specialty contact lens centers, enabling detailed mapping of irregular corneas.
High oxygen permeability materials exceeding 140 Dk are used in approximately 73% of premium scleral lenses, reducing corneal hypoxia and improving long-term wear. Clinical studies indicate that nearly 85% of keratoconus patients achieve visual acuity of 20/40 or better after successful scleral lens fitting. Dry eye management has also become a major application, with nearly 64% of severe ocular surface disease patients reporting improved comfort after regular scleral lens use. Artificial intelligence-assisted fitting software is emerging rapidly, reducing fitting chair time by approximately 22% while increasing first-fit success rates above 75%.
MARKET DYNAMICS
Driver
Rising prevalence of keratoconus and ocular surface diseases.
Increasing incidence of corneal disorders remains the strongest growth driver for the Scleral Lens Market. Keratoconus affects approximately 1 in 375 individuals in several clinical populations, while more than 20 million adults experience chronic dry eye symptoms in developed healthcare systems. Clinical evidence demonstrates that over 82% of patients using scleral lenses achieve significant visual improvement compared with conventional soft lenses. Nearly 68% of ophthalmologists recommend scleral lenses before considering corneal transplantation for advanced keratoconus.
Restraint
High fitting complexity and limited reimbursement.
Despite increasing demand, fitting complexity remains a significant challenge. Approximately 27% of patients require at least 4 fitting appointments before achieving an optimal lens fit. Nearly 39% of prospective users hesitate because of higher initial treatment costs, while reimbursement remains unavailable for approximately 44% of specialty lens procedures in many healthcare systems. More than 30% of smaller eye clinics lack advanced corneal topography systems necessary for customized fitting. Patient adaptation periods typically extend beyond 14 days for complicated corneal conditions, increasing clinician workload.
Growth in personalized specialty eye care
Opportunity
Personalized ophthalmic care presents substantial opportunities for the Scleral Lens Market. Nearly 76% of specialty eye clinics have integrated digital corneal mapping into patient assessment. Artificial intelligence-assisted lens design reduces manufacturing adjustments by approximately 24%, while customized impression-based fitting improves success rates by almost 30%.
Aging populations contribute significantly, as more than 21% of individuals above 65 years experience moderate or severe ocular surface disorders requiring advanced vision correction.
Limited specialist availability and manufacturing precision requirements
Challenge
The Scleral Lens Market continues facing challenges related to workforce shortages and precision manufacturing. Nearly 41% of patients travel more than 50 kilometers to access experienced scleral lens practitioners. Manufacturing tolerances below 0.02 mm require advanced equipment, increasing production complexity.
Approximately 19% of customized lenses require design modifications after the initial fitting because of individual corneal variations. Specialty laboratories invest heavily in precision polishing and quality inspection to maintain clinical accuracy.
SCLERAL LENS MARKET SEGMENTATION
By Type
- Mini-Scleral Lenses: Mini-scleral lenses hold approximately 58% of the Scleral Lens Market because they balance comfort, oxygen transmission, and simplified fitting procedures. Their diameters generally remain below 18 mm, making insertion easier than larger designs while maintaining complete corneal clearance. Nearly 72% of patients with moderate keratoconus achieve excellent visual improvement using mini-scleral lenses. More than 66% of first-time scleral lens users begin treatment with this category because adaptation is generally faster.
- Large-Scleral Lenses: Large-scleral lenses account for approximately 42% of the global Scleral Lens Market and remain essential for patients with advanced corneal abnormalities and severe ocular surface disorders. Lens diameters commonly exceed 18 mm, providing complete corneal vaulting and a stable fluid reservoir that supports ocular surface healing. Nearly 81% of severe dry eye patients report improved comfort after regular use of large-scleral lenses. Clinical studies indicate visual improvement exceeding 20% among patients with complex corneal scarring following customized fitting.
By Application
- Hospital: Hospitals account for approximately 29% of the global Scleral Lens Market, driven by the treatment of complex corneal diseases requiring multidisciplinary ophthalmic care. More than 68% of tertiary hospitals maintain dedicated cornea and contact lens clinics equipped with anterior segment optical coherence tomography and computerized corneal topography systems. Nearly 74% of patients referred for post-corneal transplant rehabilitation receive scleral lens evaluations before additional surgical intervention. Hospitals also manage advanced ocular surface disorders, Stevens-Johnson syndrome, and severe dry eye disease, where scleral lenses significantly improve ocular surface protection.
- Eye Clinic: Eye clinics dominate the Scleral Lens Market with approximately 56% market share owing to their specialization in advanced contact lens fitting and personalized vision correction. More than 85% of specialty scleral lens fittings are performed in independent or private eye clinics equipped with digital corneal imaging systems. Nearly 78% of keratoconus patients receive initial diagnosis and lens fitting through specialized optometric practices rather than general hospitals. Modern clinics utilize computerized lens simulation software that reduces fitting adjustments by approximately 24% while improving first-fit success above 75%.
- Others: The "Others" segment represents approximately 15% of the Scleral Lens Market and includes academic medical centers, university eye institutes, military healthcare facilities, charitable eye organizations, and specialty optical centers. More than 40% of university ophthalmology departments conduct clinical studies involving advanced scleral lens technologies and customized fitting methods. Academic institutions contribute significantly to practitioner education, with over 65% of specialty contact lens training programs incorporating scleral lens fitting modules.
-
Download Free Sample to learn more about this report
SCLERAL LENS MARKET REGIONAL INSIGHTS
-
North America
North America holds approximately 41% of the global Scleral Lens Market, making it the largest regional market. The region benefits from advanced diagnostic technologies, widespread access to specialty optometrists, and high awareness of ocular surface diseases. More than 45 million contact lens users reside across North America, while approximately 20 million adults experience chronic dry eye symptoms.
Specialty scleral lens fitting services are available in more than 70% of tertiary ophthalmology centers. Nearly 84% of specialty contact lens practitioners routinely utilize computerized corneal topography, improving diagnostic precision and fitting efficiency. The United States remains the dominant contributor, supported by more than 10,000 practicing optometrists and hundreds of corneal specialists trained in advanced scleral lens fitting.
-
Europe
Europe accounts for approximately 29% of the global Scleral Lens Market, supported by well-developed public healthcare systems, experienced ophthalmologists, and increasing diagnosis of corneal disorders. More than 120 million individuals across Europe require some form of vision correction, while specialty contact lens utilization continues increasing in university hospitals and private eye clinics.
Approximately 76% of advanced ophthalmology centers use digital corneal tomography to optimize scleral lens fitting. Countries including Germany, France, Italy, the United Kingdom, and the Netherlands lead regional adoption because of strong clinical expertise and advanced manufacturing capabilities. Nearly 69% of European keratoconus treatment centers prescribe scleral lenses before recommending surgical intervention.
-
Asia-Pacific
Asia-Pacific represents approximately 22% of the Scleral Lens Market and is experiencing increasing adoption due to expanding healthcare infrastructure, rising awareness of specialty eye care, and growing prevalence of corneal disorders. The region contains more than 60% of the global population, creating significant demand for advanced ophthalmic treatments.
Urban eye hospitals have increased investment in digital corneal imaging, with approximately 55% now operating computerized topography systems capable of customized scleral lens fitting. China, Japan, South Korea, India, and Australia remain the primary contributors to regional demand. Nearly 66% of tertiary ophthalmology hospitals across major metropolitan areas now provide specialty contact lens services.
-
Middle East & Africa
The Middle East & Africa accounts for approximately 8% of the global Scleral Lens Market and continues demonstrating gradual expansion through investments in specialty ophthalmology services. More than 50% of advanced eye hospitals in Gulf countries now offer scleral lens fitting supported by digital corneal mapping technology. Specialized ophthalmic centers continue increasing access to customized contact lens treatment for keratoconus, severe dry eye disease, and post-surgical corneal complications.
Countries including Saudi Arabia, the United Arab Emirates, South Africa, and Egypt are improving specialty eye care capacity through investments in advanced diagnostic equipment and practitioner training. Approximately 48% of referral eye hospitals have introduced computerized scleral lens fitting systems, while specialty ophthalmology education programs have increased trained practitioners by nearly 18%.
LIST OF TOP SCLERAL LENS COMPANIES
- Bausch Health
- Essilor
- ABB Optical
- Blanchard
- Art Optical
- Visionary Optics
- BostonSight
- Tru-Form Optics
- SynergEyes
- AccuLens
List Of Top 2 Companies Market Share
- Bausch Health – Approximately 20% of the global Scleral Lens Market share. The company maintains a leading position through its broad specialty contact lens portfolio, global distribution network across more than 100 countries, advanced gas-permeable lens technologies, and continuous investment in practitioner education and digital fitting solutions.
- Essilor – Approximately 15% of the global Scleral Lens Market share. The company benefits from an extensive ophthalmic care ecosystem, strong research capabilities, specialty vision correction technologies, and collaborations with eye care professionals, supporting widespread adoption of customized scleral lens solutions.
INVESTMENT ANALYSIS AND OPPORTUNITIES
Investment activity in the Scleral Lens Market is increasingly focused on digital fitting technologies, advanced gas-permeable materials, automated manufacturing, and practitioner education. More than 62% of specialty lens manufacturers have expanded investment in computer-controlled precision lathing systems capable of maintaining dimensional tolerances below 0.02 mm. Nearly 58% of ophthalmic clinics have invested in advanced corneal topography and anterior segment imaging equipment to improve fitting accuracy and reduce patient chair time.
Research funding directed toward high oxygen-permeability materials exceeding 140 Dk has increased significantly, supporting improved ocular health and longer daily wear. Approximately 47% of new investment projects emphasize artificial intelligence-assisted fitting software that reduces fitting modifications by nearly 22%. Educational investment also remains a priority, with more than 35% of specialty ophthalmic organizations expanding practitioner certification programs for scleral lens fitting. Emerging markets across Asia-Pacific and the Middle East are witnessing increasing investment in specialty eye clinics, where digital ophthalmic equipment installation has risen by approximately 28%.
NEW PRODUCT DEVELOPMENT
Innovation within the Scleral Lens Market continues to focus on customized design, improved oxygen transmission, enhanced comfort, and digital manufacturing precision. More than 71% of recently introduced scleral lens products utilize high oxygen-permeable gas-permeable polymers exceeding 140 Dk, reducing hypoxic stress during extended wear. Computer-aided design and automated manufacturing systems now produce customized lenses with precision below 0.02 mm, improving fitting consistency and reducing production variability.
Manufacturers are increasingly introducing impression-based scleral lenses designed from three-dimensional ocular surface scans, improving fit accuracy by approximately 30% for patients with highly irregular scleral anatomy. Nearly 54% of new product development programs integrate artificial intelligence-assisted fitting software capable of recommending optimized lens parameters from digital corneal maps. Hybrid polishing technologies have improved surface smoothness by approximately 18%, contributing to greater patient comfort and reduced debris accumulation beneath the lens.
FIVE RECENT DEVELOPMENTS (2023-2025)
- January 2023: BostonSight introduced an enhanced version of its scleral lens fitting platform featuring advanced digital fitting protocols and expanded practitioner training. The updated system improved fitting efficiency by approximately 20%, supported customized lens selection, and strengthened clinical management of keratoconus and severe ocular surface disease.
- June 2023: Bausch Health expanded its specialty vision care education initiatives by increasing professional scleral lens training programs across multiple international markets. The initiative included digital fitting workshops, advanced clinical education, and practitioner certification activities to improve patient access to specialty scleral lens therapy.
- March 2024: ABB Optical expanded its specialty contact lens distribution network by strengthening partnerships with independent eye care practices and specialty clinics. The initiative increased access to customized scleral lenses, enhanced practitioner support services, and improved delivery efficiency through upgraded digital ordering systems.
- September 2024: Visionary Optics introduced advanced customized scleral lens designs utilizing high oxygen-permeability materials and optimized edge profiles. Clinical evaluations demonstrated improved comfort, enhanced tear reservoir stability, and better fitting precision for patients with irregular corneal conditions and severe dry eye disease.
- February 2025: Blanchard unveiled an upgraded digital scleral lens fitting workflow incorporating advanced corneal imaging integration and precision manufacturing improvements. The development reduced fitting adjustments, enhanced customization accuracy, supported complex ocular surface disease management, and strengthened practitioner confidence in specialty lens prescribing.
SCLERAL LENS MARKET REPORT COVERAGE
The Scleral Lens Market report provides a comprehensive assessment of global industry performance, covering product innovation, technological advancement, clinical applications, competitive analysis, and regional developments. The report evaluates two major product categories, Mini-Scleral Lenses and Large-Scleral Lenses, together representing 100% of the analyzed product landscape. It also examines three major application segments, including hospitals, eye clinics, and other specialty healthcare settings, highlighting adoption patterns and patient treatment trends.
The report analyzes market performance across North America, Europe, Asia-Pacific, and the Middle East & Africa, identifying regional market shares, technological adoption rates, healthcare infrastructure, and practitioner availability. It includes detailed evaluation of specialty lens manufacturing technologies, high oxygen-permeability materials exceeding 140 Dk, digital corneal imaging, impression-based customization, and artificial intelligence-assisted fitting systems. Competitive benchmarking covers leading manufacturers, product portfolios, innovation strategies, and expansion initiatives.
| Attributes | Details |
|---|---|
|
Market Size Value In |
US$ 0.31 Billion in 2026 |
|
Market Size Value By |
US$ 0.58 Billion by 2035 |
|
Growth Rate |
CAGR of 7.24% from 2026 to 2035 |
|
Forecast Period |
2026 - 2035 |
|
Base Year |
2025 |
|
Historical Data Available |
Yes |
|
Regional Scope |
Global |
|
Segments Covered |
|
|
By Type
|
|
|
By Application
|
FAQs
The global Scleral Lens Market is expected to reach USD 0.58 Billion by 2035.
The Scleral Lens Market is expected to exhibit a CAGR of 7.24% by 2035.
Bausch Health, Essilor, ABB Optical, Blanchard, Art Optical, Visionary Optics, BostonSight, Tru-Form Optics, SynergEyes, AccuLens
In 2026, the Scleral Lens Market is estimated at USD 0.31 Billion.